Empowering People to be Ambassadors of their Own Health Since 1997.


Weekly News

Weekly news updates are currently posted on the Internet site and sent out via e-blast to provide up-to-date information on what has been covered in the news regarding lung cancer in the previous week.  Topics include all stories related to lung cancer as well as personal stories and events.

Week ending January 25, 2015

Brahmer Expects Rapid Approval for First PD-1 Inhibitor in Lung Cancer – See more at:

“Immune checkpoint inhibitors targeted against PD-1 and its ligand PD-L1 have rapidly advanced as treatments for patients with melanoma and non–small cell lung cancer (NSCLC), following their initial debut in 2012.”

Checkpoint Inhibitors Show Promise in Bladder, Lung Cancers

Madrid—“The likelihood of an objective response increases with the degree of checkpoint protein expression, according to the results of two studies of checkpoint inhibitors in patients with advanced cancers presented at the 2014 Congress of the European Society for Medical Oncology (ESMO).”

Getting answers quickly at the Lung Cancer Clinic

“Receiving a diagnosis of cancer is stressful enough, but having to wait for further tests and subsequent treatments can really add to a patient’s anxiety levels.”

Ventana Submits Lung Cancer Diagnostic Test to FDA Premarket Approval

“Ventana Medical Systems, Inc. has filed a submission with the U.S. Food and Drug Administration (FDA) requesting the premarket approval (PMA) of a diagnostic test to identify anapestic lymphoma receptor tyrosine kinase (ALK) positive lung cancer. The test, called theVENTANA ALK (D5F3) Cdx Assay, is expected to improve early diagnosis in order to provide better treatment, if the agency approves the submission, according to the company’s press release.”

Nuns provide free hospice care to cancer patients

Philadelphia — “It is called Sacred Heart Home, and its work is just that: sacred.”

UTSW Researchers Triple Survival Rates For Subset Of Stage 4 Lung Cancer Patients

“UT Southwestern Medical Center researchers have discovered a way to drastically increase the life expectancy of a subset of stage 4 lung cancer patients who previously did not respond to traditional chemotherapy alone.”

Gensignia’s research in CT lung cancer screening recognized by ASCO

“Gensignia scientific co-founders’ research has been recognized in Clinical Cancer Advances 2015: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology published online in the Journal of Clinical Oncology (JCO) on January 20, 2015.”


Caring Ambassadors Program, Inc. | P.O. Box 1748 | Oregon City, OR 97045 | 503-632-9032 | 503-632-9038 (Fax)